Recruiting NCT03908463
KOMATE Registry: Korean Multicenter Angioplasty Team
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Percutaneous coronary intervention.
- Who it may be relevant to
- Registry conditions: Coronary Artery Disease, Acute Coronary Syndrome, Myocardial Infarction, Percutaneous Coronary Intervention. Basic parameters: from 19 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The investigators will enroll the patients who underwent PCI and was based on real world clinical practice to collect the data regarding demographic, clinical, procedural information and clinical outcome using case report forms.
Interventions
- Device Percutaneous coronary intervention
All coronary intervention procedures will be performed according to current standard techniques.
Primary outcome measures
- Target lesion revascularization [Time frame: Up to 20 years]
- Target vessel revascularization [Time frame: Up to 20 years]
- Stent thrombosis [Time frame: Up to 20 years]
- Myocardial infarction [Time frame: Up to 20 years]
- Death [Time frame: Up to 20 years]
- Non-target vessel revascularization [Time frame: Up to 20 years]
- Cerebrovascular accident [Time frame: Up to 20 years]
- Major bleeding [Time frame: Up to 20 years]
- Cardiovascular readmission [Time frame: Up to 20 years]
Eligibility criteria
Inclusion criteria
- 1\. Patients older than 19 years
- 2\. Patients who undergo percutaneous coronary intervention
Exclusion criteria
- 1\. Refuse to participate
- 2\. Pregnant women or women with potential childbearing
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
South Korea · 1 center
- Division of Cardiology, Severance Cardiovascular Hospital Yonsei University College of Med — Seoul
Publications
- Cho S, Kang DY, Kim JS, Park DW, Kim IS, Kang TS, Ahn JM, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Lee SJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Jang Y, Hong MK, Park SJ. Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease. Rev Esp Cardiol (Engl Ed). 2023 Apr;76(4):245-252. doi: 10.1016/j.rec.2022.07.007. Epub 2022 Jul 27. English, Sp PMID 35907438
- Kim C, Kim JS, Kim H, Ahn SG, Cho S, Lee OH, Park JK, Shin S, Moon JY, Won H, Suh Y, Cho JR, Cho YH, Oh SJ, Lee BK, Hong SJ, Shin DH, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y. Consensus Decision-Making for the Management of Antiplatelet Therapy before Non-Cardiac Surgery in Patients Who Underwent Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents: A Cohort Study. J PMID 33843258
- Kim C, Kim JS, Kim H, Ahn SG, Cho S, Lee OH, Park JK, Shin S, Moon JY, Won H, Suh Y, Cho JR, Cho YH, Oh SJ, Lee BK, Hong SJ, Shin DH, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y. Patterns of Antiplatelet Therapy During Noncardiac Surgery in Patients With Second-Generation Drug-Eluting Stents. J Am Heart Assoc. 2020 Jun 2;9(11):e016218. doi: 10.1161/JAHA.119.016218. Epub 2020 May 16. PMID 32419586
Identifiers
NCT: NCT03908463 · 4-2018-0759